Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.36
-0.13-1.29%
Last update: Apr 21, 12:16 PM
Kazia Therapeutics Ltd Analyst Ratings
KZIANASDAQ
Kazia Therapeutics Analyst Ratings and Price Targets | NASDAQ:KZIA | Benzinga
Kazia Therapeutics Ltd has a consensus price target of $19.5 based on the ratings of 4 analysts. The high is $25 issued by Laidlaw & Co. on April 15, 2026. The low is $15 issued by Maxim Group on June 11, 2025. The 3 most-recent analyst ratings were released by Laidlaw & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 15, 2026, January 28, 2026, and December 12, 2025, respectively. With an average price target of $20.33 between Laidlaw & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 96.36% upside for Kazia Therapeutics Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Laidlaw & Co.
HC Wainwright & Co.
Maxim Group
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Kazia Therapeutics
Loading calendar...
FAQ
What is the target price for Kazia Therapeutics (KZIA) stock?
The latest price target for Kazia Therapeutics (NASDAQ:KZIA) was reported by Laidlaw & Co. on April 15, 2026. The analyst firm set a price target for $25.00 expecting KZIA to rise to within 12 months (a possible 141.43% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kazia Therapeutics (KZIA)?
The latest analyst rating for Kazia Therapeutics (NASDAQ:KZIA) was provided by Laidlaw & Co., and Kazia Therapeutics initiated their buy rating.
When was the last upgrade for Kazia Therapeutics (KZIA)?
There is no last upgrade for Kazia Therapeutics
When was the last downgrade for Kazia Therapeutics (KZIA)?
There is no last downgrade for Kazia Therapeutics.
When is the next analyst rating going to be posted or updated for Kazia Therapeutics (KZIA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kazia Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kazia Therapeutics was filed on April 15, 2026 so you should expect the next rating to be made available sometime around April 15, 2027.
Is the Analyst Rating Kazia Therapeutics (KZIA) correct?
While ratings are subjective and will change, the latest Kazia Therapeutics (KZIA) rating was a initiated with a price target of $0.00 to $25.00. The current price Kazia Therapeutics (KZIA) is trading at is $10.36, which is within the analyst’s predicted range.
